Thomas Pickron, MD
Colon & Rectal Surgery · Salt Lake City, UTNPI 1598733941
Payments from drug & device makers
What this record shows
This record is dominated by education: $35,593 of the $55,261 with a category attached, or 64.4%. Intuitive Surgical accounts for 92.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $19,401 and has fallen 78.9% since, to $4,085 in 2025.
Across 100 payments — averaging $552.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$51K
- Applied Medical Resources Corporation$4K
- AbbVie$127
- Johnson & Johnson$82
Across 59 payments — averaging $4263.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$252K
What the payments were for
- Speaking & faculty fees$5,50010%
- Travel & lodging$10,61219%
- Food & beverage$3,5566%
- Education$35,59364%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 93 | $51,099 |
| Applied Medical Resources Corporation | 4 | $3,954 |
| AbbVie | 2 | $127 |
| Johnson & Johnson | 1 | $82 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$50,000
- Gelport Laparoscopic System$3,852
How this compares
Too few colon & rectal surgery providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 40 | $204 |
| Metronidazole | 41 | $57 |
| Ondansetron OdtOndansetron | 29 | $47 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Salt Lake City
- Hyong KimSalt Lake City$248K
- Abby CrumeSalt Lake City$25K
- Joseph MelvinSalt Lake City$20K
- Matthew BobelSalt Lake City$6K
- Bryce HaacSalt Lake City$3K
- William PecheSalt Lake City$3K
- Michelle MurdaySalt Lake City$3K
- Peter BossartSalt Lake City$768
- Benjamin KimSalt Lake City$560
- Brian CainSalt Lake City$373
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.